| Regulatory B cells in anti-tumor immunity Y Zhang, N Gallastegui, JD Rosenblatt International immunology 27 (10), 521-530, 2015 | 158 | 2015 |
| Risk factors for transformation to higher-grade lymphoma and its impact on survival in a large cohort of patients with marginal zone lymphoma from a single institution JP Alderuccio, W Zhao, A Desai, N Gallastegui, J Ramdial, E Kimble, ... Journal of clinical oncology 36 (34), 3370-3380, 2018 | 73 | 2018 |
| Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation JP Alderuccio, W Zhao, A Desai, J Ramdial, N Gallastegui, E Kimble, ... American journal of hematology 94 (5), 585-596, 2019 | 31 | 2019 |
| Pulmonary embolism does not have an unusually high incidence among hospitalized COVID19 patients N Gallastegui, JY Zhou, A Drygalski, RFW Barnes, TM Fernandes, ... Clinical and Applied Thrombosis/Hemostasis 27, 1076029621996471, 2021 | 29 | 2021 |
| Resolution of fibrinogen deficiency in a patient with congenital afibrinogenemia after liver transplantation. N Gallastegui, EL Kimble, TJ Harrington Haemophilia 22 (1), 2016 | 13 | 2016 |
| Leiomyosarcoma of the splenic vein C Aguilar, F Socola, JA Donet, N Gallastegui, GA Hernandez Clinical Medicine Insights: Oncology 7, CMO. S12403, 2013 | 10 | 2013 |
| Anticoagulation for stroke prevention after restoration of haemostasis with emicizumab in acquired haemophilia A K Al-Banaa, N Gallastegui-Crestani, A von Drygalski European Journal of Case Reports in Internal Medicine 8 (11), 2021 | 9 | 2021 |
| The role of point-of-care musculoskeletal ultrasound for routine joint evaluation and management in the hemophilia clinic-a real world experience N Gallastegui, BUK Steiner, P Aguero, C Bailey, R Kruse-Jarres, DV Quon, ... BMC Musculoskeletal Disorders 23 (1), 1111, 2022 | 8 | 2022 |
| Romiplostim (Nplate®) and Oprelvekin (Neumega®) correct thrombocytopenia in TAR syndrome (thrombocytopenia with absent radii) N Gallastegui, PB Dudkiewicz, W Jy, LL Horstman, YS Ahn Blood 130, 4953, 2017 | 6 | 2017 |
| Thrombocytopenia associated with high levels of inhibin. A case study N Gallastegui, RM Coe, A Torres, TJ Harrington Blood cells, molecules & diseases 76, 22-24, 2019 | 4 | 2019 |
| Central Nervous System Involvement by Small Lymphocytic Lymphoma after a Myxoma‐Related Embolic Event N Gallastegui, DP Cassidy, DO Heros, F Vega, JH Schatz Case reports in hematology 2019 (1), 1825491, 2019 | 3 | 2019 |
| Outcomes in patients with marginal zone lymphomas undergoing transformation to high-grade lymphomas. JP Alderuccio, A Desai, N Gallastegui Crestani, J Ramdial, EL Kimble, ... Journal of Clinical Oncology 36 (15_suppl), 7559-7559, 2018 | 3 | 2018 |
| Incidence of venous thromboembolic events in hospitalized COVID-19 patients: a systematic review NG Crestani, JY Zhou, A von Drygalski, TA Morris Blood 136, 42-43, 2020 | 1 | 2020 |
| Case report: Hypereosinophilia in non-small cell lung cancer H Kwon, M Li, JD Sheldon, N Jones, NG Crestani, Z Li, DH Owen Current Problems in Cancer: Case Reports 13, 100275, 2024 | | 2024 |
| Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT? N Gallastegui, C Masias Hematology 2023 (1), 614-616, 2023 | | 2023 |
| Utilization of point-of-care musculoskeletal ultrasound for management decisions in routine hemophilia care-focus on physical therapy N Gallastegui, C Hanacek, R Kruse-Jarres, B Steiner, D Quon, C Bailey, ... HAEMOPHILIA 27, 4-5, 2021 | | 2021 |
| Validity of Quantitative Measurements By the Joint Tissue Examination and Damage Exam (JADE) with Musculoskeletal Ultrasound for the Longitudinal Assessment of Hemophilic … AM Shayeb, R Barnes, NG Crestani, C Hanacek, P Aguero, A Flores, ... Blood 136, 20-21, 2020 | | 2020 |
| Impact of Point-Of-Care Musculoskeletal Ultrasound for diagnostic and interventional decision making in the management of hemophilic arthropathy N Gallastegui, R Barnes, C Hanacek, A Flores, R Kruse-Jarres, B Steiner, ... HAEMOPHILIA 26, 89-90, 2020 | | 2020 |
| Novel Therapy for Aggressive Cutaneous T-Cell Lymphoma Leading to Complete Clinical Remission before Allogenic Stem Cell Transplantation NG Crestani, ME Ibrahim, AM Mohamed, P Romanelli, A Beitinjaneh, ... Blood 132, 5354, 2018 | | 2018 |
